BioSpace News Archive

Policy

FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention

The Federal Trade Commission’s lawsuit takes an unusual strategy, according to legal experts, raising concerns and uncertainties in the biopharma industry.

June 7, 2023
·
4 min read
·
Lisa Munger
Polaris Group’s Strategic Partner Nanotein Technologies Launches GROW-NK, a Revolutionary NK Cell Activation and Expansion Reagent, Propelling the Field of NK Cell Therapy

Polaris Group (TWSE: 6550), a multinational biopharmaceutical company focused on research and development of novel biological drugs for cancer and other metabolic diseases, today announced...

June 7, 2023
·
2 min read
Drug Development

FibroGen’s Duchenne Muscular Dystrophy Drug Fails Phase III Trial

In a late-stage study of non-ambulatory patients with DMD on background corticosteroids, pamrevlumab failed to meet the primary endpoint for upper limb performance.

June 7, 2023
·
2 min read
·
Kate Goodwin
Policy

Moderna, Pfizer Hit with New COVID Vaccine Patent Lawsuits

Promosome filed lawsuits Tuesday against Moderna and Pfizer/BioNTech, alleging that the vaccine developers used patent-protected mRNA technology without a license.

June 7, 2023
·
2 min read
·
Tristan Manalac
Study: Biosimilars ‘Fulfilling Their Promise’ of Lowering Biologic Prices

Biosimilars effectively lowered cancer therapy Herceptin prices and made trastuzumab more accessible to patients, finds a new study from the USC Schaeffer Center.

June 7, 2023
·
2 min read
·
Tristan Manalac
Drug Development

FDA Adcomm Unanimously Backs Full Approval of Eisai, Biogen’s Leqembi

In a 6-0 vote, the FDA’s advisory committee Friday affirmed that trial data confirmed the clinical benefit of Eisai and Biogen’s Leqembi (lecanemab) for the treatment of Alzheimer’s disease.

June 7, 2023
·
3 min read
·
Rosemary Scott
Policy

CAP and ASCO Reaffirm Current HER2 Testing Guidelines, Reducing Confusion

The College of American Pathologists and American Society of Clinical Oncology have reaffirmed the Human Epidermal Growth Factor Receptor 2 Breast Cancer Testing Guidelines, reducing confusion over terminology for reporting HER2 results.

June 7, 2023
·
3 min read
Genetown

Integrity: A Fundamental Value

Quest’s vision is to empower better health through diagnostic insights. Our ability to achieve that vision is dependent on one of our key values, integrity.

June 7, 2023
·
5 min read
Genetown

hC Bioscience’s Preclinical Study Shows Promise for tRNA-Based Cancer Therapy

hC Bioscience announced its tRNA-based therapy demonstrated proof-of-concept in an in vivo model of metastatic colorectal cancer with 75% tumor growth inhibition.

June 7, 2023
·
1 min read
Business

SHINE Technologies Appoints Experienced Company Builder to Board of Directors

SHINE Technologies, LLC, a next-generation fusion technology company, announced the appointment of Dr. Frederick Robertson to the company’s board of directors.

June 7, 2023
·
2 min read